LifeStance Q4 revenue $382M (+17% YoY); net income $11.7M; $100M buyback; Chairman transition

LifeStance Health Group, Inc.

Q4 revenue $382.2M (+17% YoY); full-year revenue $1.42B (+14% YoY).
Q4 net income $11.7M vs loss $7.1M; full-year net income $9.7M vs loss $57.4M.
Adjusted EBITDA Q4 $48.8M (+49% YoY); full-year $157.7M (+32% YoY).
2026 guidance: revenue $1.615B-$1.655B; Adjusted EBITDA $185M-$205M.
Board approved $100M share repurchase; Kenneth Burdick transitions to non-executive Chairman effective Mar 16, 2026.

item 2.02 item 5.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.